6cc bioengineered bone graft (class III combination product) for the treatment of ankle and hindfoot fusions that provides a porous, osteoconductive scaffold to support cell attachment and growth. (B-TCP granules + rhPDGF-BB solution) Needed for patient surgery scheduled for 31 March 2016.
Bid Protests Not Available